Amylyx Pharmaceuticals

Company dedicated to the development of potential therapies for neurodegenerative diseases

Based in MA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $990K in lobbying spend across 17 quarterly filings, Amylyx Pharmaceuticals is an active lobbying client. They deploy 12 individual lobbyists Their lobbying covers 2 issue areas. Active from 2022 to 2025.

$990K
Total Spend
4
Years Active
1
Firms Hired
12
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$270K
2023$320K
2024$240K
2025$160K

Issues Lobbied

Health IssuesMedicare/Medicaid

Lobbying Firms

Tarplin, Downs & Young, LLC

Lobbyists

Elizabeth MurrayCharlotte IvancicEmily MurryKimberly BrandtRaissa DownsMichelle EastonJennifer YoungPamela SmithMargaret JosephPeter FiseLaura FriedelParick Carroll

Government Agencies Targeted

These are the government entities that Amylyx Pharmaceuticals disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

ALS and access to innovation

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Akebia Therapeutics, INC.
$9.8M total spend
Ardelyx, INC.
$9.4M total spend
Sage Therapeutics
$4.8M total spend
Organogenesis INC.
$4.0M total spend
Beone Medicines USA, INC (Formerly Beigene USA, INC.)
$3.5M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.